Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
82.35
-0.94 (-1.13%)
At close: Jul 21, 2026, 4:00 PM EDT
82.06
-0.29 (-0.35%)
After-hours: Jul 21, 2026, 7:57 PM EDT

Medtronic Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Quarter
Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Period Ending
Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21 Jul '21
Net Income
1,2591,1501,3811,0471,0611,3031,2781,0496601,3379117971,1891,2284369311,4921,4841,317769
Depreciation & Amortization
716749745748840684675662654649672672679679671668688672676671
Stock-Based Compensation
959418286899815983908414673758113762727814069
Other Adjustments
6048393548825-939778-10627156-4161-21171-315-179-34635
Change in Receivables
-28713-214288-249-3-291110-251-23-281164-168-62-43589-265-41-131-40
Changes in Inventories
399-131-299-373186-200-61-21739186-206-410-3-152-404-380-201-203-81-75
Changes in Accounts Payable
123703-182-598366550-103-604644446-26-673533177133-147207452-30-416
Changes in Other Operating Activities
209117-727-464147115-606-1941401-58296196-438405-311379-35-88-321
Operating Cash Flow
2,5732,7449251,0882,5282,5729589862,7772,4746618752,4601,5749221,0832,0572,2281,7691,292
Operating Cash Flow Growth
1.78%6.69%-3.45%10.35%-8.97%3.96%44.93%12.69%12.89%57.18%-28.31%-19.21%19.59%-29.35%-47.88%-16.18%17.88%-5.43%-4.94%364.75%
Capital Expenditures
-488-444-468-504-459-476-404-520-426-346-461-354-378-332-323-426-389-330-271-378
Purchases of Investments
-2,153-2,371-2,101-2,100-2,133-2,074-2,140-1,879-2,326-2,019-1,487-1,916-2,042-1,729-1,859-1,884-1,963-2,608-2,657-2,654
Proceeds from Sale of Investments
2,1232,0241,9482,0102,2401,9172,1812,1572,2991,8061,5881,7481,9561,7781,7231,8862,5622,4932,3132,324
Payments for Business Acquisitions
-406---0----137-52--00-676-1,19100-91-
Other Investing Activities
6-24139-125-138-11218-17-106-96-42-17-11-4-1130618-3-76
Investing Cash Flow
-917-816-482-719-490-843-345-259-696-707-424-539-475-287-1,146-1,585271-437-709-784
Short-Term Debt Issued
------------0002,284----
Net Short-Term Debt Issued (Repaid)
------------0002,284----
Long-Term Debt Issued
001,747-0003,209----1,9790------
Long-Term Debt Repaid
00-1,768-1,162---------2,929-7720-2,311000-1
Net Long-Term Debt Issued (Repaid)
00-21-1,1620003,209-----950-7720-2,311000-1
Issuance of Common Stock
971641609510816814389785772779956110438570163111
Repurchase of Common Stock
-435-105-372-123-274-181-288-2,492-1,628-132-226-152-97-71-141-336-1,406-394-429-315
Net Common Stock Issued (Repurchased)
-33859-212-28-166-13-145-2,403-1,550-75-154-752-15-31-293-1,321-324-266-204
Common Dividends Paid
-908-911-910-910-897-897-897-898-913-917-918-918-905-904-904-903-843-847-847-846
Other Financing Activities
-180-1,234748719-280-843508-639104-508982492-758-443519273215-6-42-4
Financing Cash Flow
-888-2,087-395-1,381-1,343-1,753-534-731-2,359-1,500-90-501-4,890-2,1343,014-950-1,949-1,177-1,155-1,055
Effect of Exchange Rate Changes on Cash and Cash Equivalents
3324-3967283-130431-6044-175-39-74540-101-122-144-36-9-42
Net Cash Flow
803-1369-945978-1548327-339312-28-204-2,979-3062,688-1,574235579-104-589
Free Cash Flow
2,0852,3004575842,0692,0965544662,3512,1282005212,0821,2425996571,6681,8981,498914
Free Cash Flow Growth
0.77%9.73%-17.51%25.32%-12.00%-1.50%177.00%-10.56%12.92%71.34%-66.61%-20.70%24.82%-34.56%-60.01%-28.12%21.93%-4.77%-5.19%-
FCF Margin
21.26%25.51%5.10%6.81%23.18%25.28%6.59%5.89%27.37%26.31%2.51%6.76%24.37%16.07%7.90%8.91%20.62%24.45%19.09%11.44%
Free Cash Flow Per Share
1.621.780.350.451.611.630.430.361.771.600.150.391.560.930.450.491.241.411.110.67
Levered Free Cash Flow
2,2032,137422-1,3132,1361,9677713,3782,0572,1583061221,2563849093062,1692,0361,517243
Unlevered Free Cash Flow
2,2452,193528.02-29.012,2892,066808.51183.272,2132,183326.73174.922,2271,178920.81408.312,2402,1041,585274
SEC Filings: 10-K · 10-Q